|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 376.37 USD | +1.31% |
|
-0.02% | +13.50% |
| 07:25am | CuraTeQ Biologics Wins European Medicines Agency's Positive Opinion for Neulasta Biosimilar | MT |
| 02:42am | Abivax strengthens its commercial leadership team |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Neutral | Bullish |
| Resistance | 374.15 | 388.16 | 388.16 |
| Spread/Res. | -0.71% | -4.29% | -4.29% |
| Spread/Supp. | +4.59% | +14.71% | +13.92% |
| Support | 355.2 | 323.85 | 326.1 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- AMGN Stock
- Charts Amgen Inc.
Select your edition
All financial news and data tailored to specific country editions
















